Skip to main content
OpenTrials
Completed

NCT Number: NCT01162759

Home Blood Pressure Monitoring Project

The goal of this project is to improve hypertension control at Kaiser Permanente Colorado (KPCO) by implementing a population-based multi-factorial intervention that uses home BP monitors that can download BP readings to KPCO's health records via internet, interactive voice response (IVR) technology, and multidisciplinary care team. Participants will be randomized to either the home blood pressure monitoring group receiving the multi-factorial intervention or the usual care group who will be receiving Kaiser standard of care. We will determine the proportion of patients in each group who achieve their target BP goals at 6 months, according to national clinical practice guidelines. The study hypothesis is that a higher proportion of patients with uncontrolled hypertension in the home blood pressure monitoring (HBPM) group will achieve their target blood pressure compared to those in the usual care (UC) group.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Cardiovascular Diseases Vascular Diseases

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kaiser Permanente Colorado, Institute of Health Research

Denver, Colorado, 80231, United States

About this study

STUDY OBJECTIVES:

Primary:

  • To determine the proportion of patients in each group who achieve their target BP goals at 6 months, according to national clinical practice guidelines

Secondary:

The following parameters will be evaluated between groups:

  • Change in BP measures between baseline and at 6 months
  • Proportion of patients who are receiving antihypertensive treatments in accordance to national clinical practice guidelines
  • Adherence to hypertensive medication regimen during the 6-month follow-up period
  • Patient satisfaction with the care model.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 85 years At least 1 diagnosis for hypertension,
  • Receive primary care from one of the participating clinics,
  • The two most recent BPs documented within that last 24 months are elevated (SBP>140 and/or DBP>90)
  • Receiving < 3 antihypertensive medications, and
  • Have access to a computer with a USB port.

Exclusion criteria

  • Pregnant, or breast-feeding,
  • Patients on dialysis or being followed by nephrology,
  • Patients with coronary artery disease, given these patients are already followed by the Clinical Pharmacy Cardiac Risk Service (CPCRS),
  • On KPCO "Do Not Call" or deceased list,
  • PCP does not give permission to include patient in the study,
  • BP is at or below target at the baseline study visit,
  • Not English-speaking.

Treatment and study plan

Home Blood Pressure Monitoring

Behavioral

Home blood pressure readings are taken at least 3 times a week, uploaded to a Microsoft Health Vault account through American Heart Association Heart360 at least 1 time per week. Patients are followed by a clinical pharmacist, with physician oversight, who will make adjustments to antihypertensive medications or suggest additional medications using national JNC VII and KPCO hypertension guidelines.

Other names: HBPM

Primary outcomes

  1. BP at 6 months

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Kaiser Permanente

Other

Collaborators

  • American Heart Association

Registry information

Official study title

Home Blood Pressure Monitoring Program

Acronym: HBPM

Important dates

Study start
2008
Primary completion
2010
Study completion
2010
First posted
Jul 15, 2010
Registry last updated
Apr 6, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.